References
1. Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, et al.
Global causes of maternal death: A WHO systematic analysis. Lancet Glob
Health. 2014;2(6):e323–33
2. O’Brien KL, Shainker SA, Lockhart EL. Transfusion management of
obstetric hemorrhage. Transfus Med Rev. 2018;32(4):249–55
3. Weeks A. The prevention and treatment of postpartum haemorrhage: What
do we know, and where do we go to next? BJOG. 2015;122(2):202–10
4. Committee on Practice Bulletins – Obstetrics. Practice Bulletin
number 183. Practice Bulletin No. 183: Postpartum hemorrhage. Obstet
Gynecol. 2017;130(4):e168–86
5. Wang Y, Han W, Pan L, Wang C, Liu Y, Hu W, et al. Impact of COVID-19
on blood centres in Zhejiang Province China. Vox Sang. 2020
6. Baron DM, Franchini M, Goobie SM, Javidroozi M, Klein AA, Lasocki S,
et al. Patient blood management during the COVID-19 pandemic: A
narrative review. Anaesthesia. 2020
7. Sakai H. Overview of potential clinical applications of hemoglobin
vesicles (HbV) as artificial red cells, evidenced by preclinical studies
of the Academic Research Consortium. J Funct Biomater. 2017;8(1):10
8. Natanson C, Kern SJ, Lurie P, Banks SM, Wolfe SM. Cell-free
hemoglobin-based blood substitutes and risk of myocardial infarction and
death: A meta-analysis. JAMA. 2008;299(19):2304–12
9. Chang TM. Semipermeable microcapsules. Science. 1964;146(3643):524–5
10. Sakai H, Sou K, Tsuchida E. Hemoglobin-vesicles as an artificial
oxygen carrier. Methods Enzymol. 2009;465:363–84
11. Taguchi K, Miyasato M, Ujihira H, Watanabe H, Kadowaki D, Sakai H,
et al. Hepatically-metabolized and -excreted artificial oxygen carrier,
hemoglobin vesicles, can be safely used under conditions of hepatic
impairment. Toxicol Appl Pharmacol. 2010;248(3):234–41
12. Takahashi D, Azuma H, Sakai H, Sou K, Wakita D, Abe H, et al.
Phagocytosis of liposome particles by rat splenic immature monocytes
makes them transiently and highly immunosuppressive in ex vivo culture
conditions. J Pharmacol Exp Ther. 2011;337(1):42–9
13. Sakai H, Suzuki Y, Sou K, Kano M. Cardiopulmonary hemodynamic
responses to the small injection of hemoglobin vesicles (artificial
oxygen carriers) in miniature pigs. J Biomed Mater Res A.2012;100(10):2668–77
14. Taguchi K, Urata Y, Anraku M, Watanabe H, Kadowaki D, et al.
Hemoglobin vesicles, polyethylene glycol (PEG)ylated liposomes developed
as a red blood cell substitute, do not induce the accelerated blood
clearance phenomenon in mice. Drug Metab Dispos. 2009;37(11):2197–203
15. Sakai H, Masada Y, Horinouchi H, Ikeda E, Sou K, Takeoka S, et al.
Physiological capacity of the reticuloendothelial system for the
degradation of hemoglobin vesicles (artificial oxygen carriers) after
massive intravenous doses by daily repeated infusions for 14 days. J
Pharmacol Exp Ther. 2004;311(3):874–84
16. Seishi Y, Horinouchi H, Sakai H, Kobayashi K. Effect of the
cellular-type artificial oxygen carrier hemoglobin vesicle as a
resuscitative fluid for prehospital treatment: Experiments in a rat
uncontrolled hemorrhagic shock model. Shock. 2012;38(2):153–8
17. Hagisawa K, Kinoshita M, Takase B, Hashimoto K, Saitoh D, Seki S, et
al. Efficacy of resuscitative transfusion with hemoglobin vesicles in
the treatment of massive hemorrhage in rabbits with thrombocytopenic
coagulopathy and its effect on hemostasis by platelet transfusion.
Shock. 2018;50(3):324–30
18. Tokuno M, Taguchi K, Yamasaki K, Sakai H, Otagiri M. Long-term
stored hemoglobin-vesicles, a cellular type of hemoglobin-based oxygen
carrier, has resuscitative effects comparable to that for fresh red
blood cells in a rat model with massive hemorrhage without
post-transfusion lung injury. PLOS ONE. 2016;11(10):e0165557
19. Sakai H, Sou K, Horinouchi H, Kobayashi K, Tsuchida E.
Haemoglobin-vesicles as artificial oxygen carriers: Present situation
and future visions. J Intern Med. 2008;263(1):4–15
20. Waters JH. Role of the massive transfusion protocol in the
management of haemorrhagic shock. Br J Anaesth. 2014;113(Suppl 2):ii3–8
21. Yu YH, Gong SP, Sheng C, Zhao KS, Lodato RF, Wang CH. Increased
survival with hypotensive resuscitation in a rabbit model of
uncontrolled hemorrhagic shock in pregnancy. Resuscitation.2009;80(12):1424–30
22. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving
bioscience research reporting: The ARRIVE Guidelines for Reporting
Animal Research. PLOS Biol. 2010;8(6):e1000412
23. Hagisawa K, Kinoshita M, Takikawa M, Takeoka S, Saitoh D, Seki S, et
al. Combination therapy using fibrinogen γ-chain peptide-coated,
ADP-encapsulated liposomes and hemoglobin vesicles for trauma-induced
massive hemorrhage in thrombocytopenic rabbits. Transfusion.2019;59(10):3186–96
24. Taguchi K, Watanabe H. A fourteen-day observation and
pharmacokinetic evaluation after a massive intravenous infusion of
hemoglobin-vesicles (artificial oxygen carriers) in cynomolgus monkeys.
J Drug Metab Toxicol. 2012;3(4):128
25. Kawaguchi R, Matsumoto K, Akira S, Ishitani K, Iwasaku K, Ueda Y, et
al. Guidelines for office gynecology in Japan: Japan Society of
Obstetrics and Gynecology (JSOG) and Japan Association of Obstetricians
and Gynecologists (JAOG) 2017 edition. J Obstet Gynaecol Res. 2019.
Japan Society of Obstetrics and Gynecology;45(4):766–86
26. Diehl KH, Hull R, Morton D, Pfister R, Rabemampianina Y, Smith D, et
al. A good practice guide to the administration of substances and
removal of blood, including routes and volumes. J Appl Toxicol.
2001;21(1):15–23
27. Cannon JW. Hemorrhagic shock. N Engl J Med. 2018;378(4):370–9
28. Faul F, Erdfelder E, Lang AG, Buchner AG. G*Power 3: A flexible
statistical power analysis program for the social, behavioral, and
biomedical sciences. Behav Res Methods. 2007;39(2):175–91
29. Barroso J, Osborne B, Teramura
G, Pellham E, Fitzpatrick M, Biehl R, et al. Safety evaluation of a
lyophilized platelet-derived hemostatic product. Transfusion.2018;58(12):2969–77
30. Prick BW, Jansen AJ, Steegers EA, Hop WC, Essink-Bot ML, Uyl-de
Groot CA, et al. Transfusion policy after severe postpartum haemorrhage:
a randomised non-inferiority trial. BJOG. 2014;121(8):1005–14.
31. Chessman J, Patterson J, Nippita T, Drayton B, Ford J. Haemoglobin
concentration following postpartum haemorrhage and the association
between blood transfusion and breastfeeding: a retrospective cohort
study. BMC Res Notes. 2018;11(1):686.
32. Moon PF, Bliss SP, Posner LP, Erb HN, Nathanielsz PW. Fetal oxygen
content is restored after maternal hemorrhage and fluid replacement with
polymerized bovine hemoglobin, but not with hetastarch, in pregnant
sheep. Anesth Analg. 2001;93(1):142–50.
33. Wigger O, Bloechlinger S, Berger D, Häner J, Zanchin T, Windecker S,
et al. Baseline serum bicarbonate levels independently predict
short-term mortality in critically ill patients with ischaemic
cardiogenic shock. Eur Heart J Acute Cardiovasc Care.2018;7(1):45–52
34. Olofsson C, Ahl T, Johansson T, Larsson S, Nellgård P, Ponzer S, et
al. A multicenter clinical study of the safety and activity of
maleimide-polyethylene glycol-modified hemoglobin (Hemospan) in patients
undergoing major orthopedic surgery. Anesthesiology.2006;105(6):1153–63
35. Jahr JS, Mackenzie C, Pearce LB, Pitman A, Greenburg AG. HBOC-201 as
an alternative to blood transfusion: Efficacy and safety evaluation in a
multicenter phase III trial in elective orthopedic surgery. J
Trauma. 2008;64(6):1484–97
36. Li H, Ohta H, Tahara Y, Nakamura S, Taguchi K, Nakagawa M, et al.
Artificial oxygen carriers rescue placental hypoxia and improve fetal
development in the rat pre-eclampsia model [sci. rep. :15271].
Sci Rep. 2015;5:15271